Aakash Desai: Our latest research at ESMO24 on HER2 Expression across Solid Tumors

Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared on LinkedIn:

“Excited to present our latest research at ESMO24 on HER2 Expression across Solid Tumors and its Real-World Implications for the Use of fam-trastuzumab deruxtecan-nxki (T-DXd)! ESMO – European Society for Medical Oncology, UAB O’Neal Comprehensive Cancer Center

Our study delves deep into the varying expression of HER2 across different solid tumors and provides valuable insights into the practical use of T-DXd in clinical settings.

Here are some key takeaways:

• Diverse Expression Patterns: HER2 shows a wide range of expression levels across different tumor types, underscoring the complexity and variability in tumor biology.
• Real-World Data: The study highlights the significance of real-world evidence in understanding HER2 expression and tailoring treatment strategies accordingly.”

Source: Aakash Desai/LinkedIn